CASI

NASDAQ · Biotechnology

Casi Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$0.92

-0.03 (-2.66%)

As of Feb 8, 2:27 PM ET ·

Income Statement

	FY 2025	FY 2024	FY 2023
Revenue	9.76M	9.51M	9.21M
Net Income	476.4K	434.3K	561.3K
EPS	—	—	—
Profit Margin	4.9%	4.6%	6.1%
Rev Growth	+1.2%	+3.9%	+7.8%

Balance Sheet

	FY 2025	FY 2024	FY 2023
Total Debt	1.78M	2.23M	2.01M
Total Equity	5.82M	5.80M	5.32M
D/E Ratio	0.31	0.38	0.38

Cash Flow

	FY 2025	FY 2024	FY 2023
EBITDA	702.0K	716.5K	618.7K
Free Cash Flow	456.1K	350.1K	392.2K